查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590712

食物過敏診斷和治療市場：按產品類型、技術、來源、成分和最終用戶 - 2025-2030 年全球預測

Food Allergy Diagnostics & Therapeutics Market by Product Type (Diagnostic Tests Type, Therapeutic Treatment Type), Technology (Enzyme-Linked Immunosorbent Assay, Polymerase Chain Reaction), Source, Component, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年食物過敏診斷和治療藥物市場規模預計為58.6億美元，預計2024年將達到64.3億美元，複合年成長率為10.35%，2030年將達到116億美元。

食物過敏診斷和治療市場主要包括旨在識別和管理食物過敏的產品和服務，從診斷測試到治療解決方案。這些技術的需求源於食物過敏的全球流行，它影響著數百萬人的生活，需要準確的診斷和有效的治療，以提高生活品質並降低醫療費用。應用範圍從使用體外和分子過敏原診斷的臨床環境到個人消費者的家庭檢測套組。最終用途範圍包括專門從事過敏和免疫學的醫院、診所和研究機構。關鍵的成長要素包括人們對食物過敏的認知提高、生物技術的進步以及研發投資的增加。最新的潛在機會在於開發新型生技藥品、低過敏性食品和針對個人過敏原特徵的個人化醫療方法。利用數位健康進步來進行病患教育和治療依從性也是一個重要的成長途徑。

主要市場統計
基準年[2023] 58.6億美元
預測年份 [2024] 64.3億美元
預測年份 [2030] 116.9億美元
複合年成長率（%） 10.35%

然而，該市場面臨一些限制，例如先進診斷測試的高成本、監管障礙以及食物過敏症狀的變異性，使診斷和治療的標準化變得複雜。另一個主要問題是由於缺乏意識和基礎設施，發展中地區採用緩慢。為了促進創新，公司應該專注於開發具有成本效益的非侵入性診斷技術，加強食品過敏原標籤，並投資人工智慧和機器學習來預測過敏趨勢和治療效果。此外，與研究機構合作探索腸道微生物治療方法可能會提供有希望的見解。儘管面臨挑戰，市場仍然充滿活力，並以大量的研發活動和創新解決方案的穩定湧入為特徵。隨著對更準確診斷和有效治療方法的需求增加，該行業已做好擴張的準備，而利用技術和戰略夥伴關係關係的公司可能會獲得競爭優勢。

市場動態：快速發展的食物過敏診斷和治療市場的關鍵市場洞察

由於供需的動態交互作用，食物過敏診斷和治療藥物市場正在經歷轉型。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 兒童和成人過敏性疾病增加
    • 組織增加對食物過敏診斷的資助
    • 患者對體外診斷血液檢測的需求增加
  • 市場限制因素
    • 對食物過敏檢測方法的認知度和實施率下降
  • 市場機會
    • 食物過敏診斷和治療方法的技術不斷進步
    • 增加藥物開發的舉措
  • 市場挑戰
    • 嚴格的食物過敏診療藥物法規結構

波特五力：引領食物過敏診斷與治療藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對食物過敏診斷和治療藥物市場的影響

外部宏觀環境因素在塑造食物過敏診斷和治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解食物過敏診斷和治療藥物市場的競爭狀況

食物過敏診斷和治療市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣供應商在食物過敏診斷與治療市場的績效評估

FPNV定位矩陣是評估食物過敏診斷和治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 規劃食物過敏診斷與治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，食物過敏診斷和治療市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 兒童和成人過敏性疾病的發生率增加
      • 組織增加對食物過敏診斷的資助
      • 患者對體外診斷血液檢測的需求增加
    • 抑制因素
      • 食品過敏測試方法很少被認可並且很少實施。
    • 機會
      • 食物過敏診斷和治療技術不斷進步
      • 加大藥物開發的研發力度
    • 任務
      • 嚴格的食物過敏診斷和治療法規結構
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章食物過敏診斷與治療藥物市場：依產品類型

  • 診斷測試的類型
    • 體外
    • 體內/皮膚
      • 斑貼試驗
      • 皮膚點刺試驗
  • 治療類型
    • 抗組織胺藥
    • 腎上腺素自動注射器

第7章食物過敏診斷與治療藥物市場：依技術分類

  • 酵素免疫分析法
  • 聚合酵素鏈鎖反應

第8章食物過敏診斷與治療市場：依來源分類

  • 蛋
  • 魚
  • 牛奶
  • 花生
  • 貝類
  • 大豆
  • 堅果
  • 小麥

第9章食物過敏診斷和治療藥物市場：按組成部分

  • 消耗品
  • 裝置
  • 服務

第10章食物過敏診斷與治療藥物市場：依最終使用者分類

  • 學術研究所
  • 診斷實驗室
  • 醫院/診所

第11章北美和南美食物過敏診斷和治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區食物過敏診斷及治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲食物過敏診斷和治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Aleph Farm 透過收購 VBL Therapeutics 設施並與 ESCO Aster 合作提高產能
    • Jealous Pass Labs 在印度擴大過敏測試範圍
    • Deeside公司取得食品過敏診斷美國專利
    • 「Thermo Fisher 小麥和芝麻過敏血液檢測獲得 FDA核准
    • CoreRx, Inc. 宣布 Aimmune Therapeutics 花生過敏治療藥物商業供應協議 - CoreRx(R)
    • Lantheus 宣布合作支持攝護腺癌的臨床開發
    • Allergy Therapeutics 選擇 AGC Biologics 生產花生過敏候選疫苗
    • FDA核准花生過敏候選藥物的IND申請
    • Praetura Ventures主導對食品過敏診斷公司 290 萬英鎊的投資
    • Ukko 融資 4000 萬美元，利用人工智慧解決食物過敏問題
  • 戰略分析和建議

公司名單

  • 7 Drops Diagnostics, Inc.
  • ACON Laboratories, Inc.
  • AESKU.GROUP GmbH
  • ALK-Abello A/S
  • Allergy Therapeutics PLC
  • Alpha Laboratories
  • Apexhealth by Acecgt Diagnostic Limited
  • Apollo Diagnostics
  • Aster Clinical Lab LLP
  • Astra Biotech GmbH
  • bioMerieux SA
  • Cerascreen GmbH
  • Eurofins Scientific（Ireland）Limited
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HollisterStier Allergy by Jubilant Pharma Holdings Inc.
  • HYCOR Biomedical
  • Indoor Biotechnologies, Inc.
  • Laboratory Corporation of America Holdings.
  • Lincoln Diagnostics, Inc.
  • Medeca Pharma AB
  • Microbac Laboratories, Inc.
  • Minaris Medical America, Inc.
  • Neogen Corporatio
  • Nestle Health Science
  • Omega Diagnostics Group PLC
  • Prota Therapeutics Pty. Ltd.
  • Quest Consumer Inc.
  • R-Biopharm AG
  • Romer Labs Division Holding GmbH
  • ROXALL Medizin GmbH
  • Siemens AG
  • STALLERGENES GREER International AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-ED54C46E8118

The Food Allergy Diagnostics & Therapeutics Market was valued at USD 5.86 billion in 2023, expected to reach USD 6.43 billion in 2024, and is projected to grow at a CAGR of 10.35%, to USD 11.69 billion by 2030.

The food allergy diagnostics and therapeutics market primarily encompasses products and services aimed at identifying and managing food allergies, from diagnostic tests to therapeutic solutions. The necessity for these technologies arises from a growing prevalence of food allergies globally, impacting millions of lives and necessitating accurate diagnostics and effective treatments to enhance quality of life and reduce healthcare costs. Applications range from clinical settings, where in vitro and molecular allergen diagnostics are used, to at-home testing kits for individual consumer use. The end-use scope includes hospitals, clinics, and research institutions focused on allergy and immunology. Key growth influencers include rising awareness of food allergies, advancements in biotechnology, and increasing investments in research and development. The latest potential opportunities lie in the development of novel biologics, hypoallergenic food products, and personalized medicine approaches tailored to individual allergen profiles. Exploiting advancements in digital health for patient education and adherence to therapies also presents substantial growth avenues.

KEY MARKET STATISTICS
Base Year [2023] USD 5.86 billion
Estimated Year [2024] USD 6.43 billion
Forecast Year [2030] USD 11.69 billion
CAGR (%) 10.35%

However, the market faces limitations such as high costs of advanced diagnostic tests, regulatory hurdles, and variability in food allergy manifestations that complicate standardization in diagnostics and treatment. Slow adoption in developing regions due to lack of awareness and infrastructure also poses significant challenges. To foster innovation, businesses can focus on developing cost-effective, non-invasive diagnostic technologies, enhancing food allergen labeling, and investing in AI and machine learning to predict allergy trends and treatment effectiveness. Additionally, collaboration with research institutions to explore gut microbiome therapies could offer promising insights. Despite its challenges, the market is dynamic, marked by significant research and development activities and a steady influx of innovative solutions. As the demand for more precise diagnosis and effective therapeutics grows, the industry is poised for expansion, with companies that leverage technology and strategic partnerships likely to gain a competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Food Allergy Diagnostics & Therapeutics Market

The Food Allergy Diagnostics & Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of allergic conditions among pediatric and adult populations
    • Increasing funds by organizations in food allergy diagnostics
    • Rising patient demand for in vitro diagnostic blood tests
  • Market Restraints
    • Limited awareness and less implementation of food allergic testing methods
  • Market Opportunities
    • Ongoing technological advancements in food allergy diagnostics and therapeutics
    • Increasing number of research and development initiatives for the development of drugs
  • Market Challenges
    • Stringent regulatory framework for food allergy diagnostics and therapeutics

Porter's Five Forces: A Strategic Tool for Navigating the Food Allergy Diagnostics & Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Food Allergy Diagnostics & Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Food Allergy Diagnostics & Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Food Allergy Diagnostics & Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Food Allergy Diagnostics & Therapeutics Market

A detailed market share analysis in the Food Allergy Diagnostics & Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Food Allergy Diagnostics & Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Food Allergy Diagnostics & Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Food Allergy Diagnostics & Therapeutics Market

A strategic analysis of the Food Allergy Diagnostics & Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Food Allergy Diagnostics & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 7 Drops Diagnostics, Inc., ACON Laboratories, Inc., AESKU.GROUP GmbH, ALK-Abello A/S, Allergy Therapeutics PLC, Alpha Laboratories, Apexhealth by Acecgt Diagnostic Limited, Apollo Diagnostics, Aster Clinical Lab LLP, Astra Biotech GmbH, bioMerieux SA, Cerascreen GmbH, Eurofins Scientific (Ireland) Limited, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy by Jubilant Pharma Holdings Inc., HYCOR Biomedical, Indoor Biotechnologies, Inc., Laboratory Corporation of America Holdings., Lincoln Diagnostics, Inc., Medeca Pharma AB, Microbac Laboratories, Inc., Minaris Medical America, Inc., Neogen Corporatio, Nestle Health Science, Omega Diagnostics Group PLC, Prota Therapeutics Pty. Ltd., Quest Consumer Inc., R-Biopharm AG, Romer Labs Division Holding GmbH, ROXALL Medizin GmbH, Siemens AG, STALLERGENES GREER International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Food Allergy Diagnostics & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Diagnostic Tests Type and Therapeutic Treatment Type. The Diagnostic Tests Type is further studied across In Vitro and In Vivo/Skin. The In Vivo/Skin is further studied across Patch Test and Skin Prick Test. The Therapeutic Treatment Type is further studied across Antihistamines and Epinephrine Auto-Injector.
  • Based on Technology, market is studied across Enzyme-Linked Immunosorbent Assay and Polymerase Chain Reaction.
  • Based on Source, market is studied across Eggs, Fish, Milk, Peanuts, Shellfish, Soy, Tree Nuts, and Wheat.
  • Based on Component, market is studied across Consumables, Instruments, and Services.
  • Based on End-User, market is studied across Academic Research Institutes, Diagnostics Laboratories, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of allergic conditions among pediatric and adult populations
      • 5.1.1.2. Increasing funds by organizations in food allergy diagnostics
      • 5.1.1.3. Rising patient demand for in vitro diagnostic blood tests
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and less implementation of food allergic testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements in food allergy diagnostics and therapeutics
      • 5.1.3.2. Increasing number of research and development initiatives for the development of drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework for food allergy diagnostics and therapeutics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Food Allergy Diagnostics & Therapeutics Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostic Tests Type
    • 6.2.1. In Vitro
    • 6.2.2. In Vivo/Skin
      • 6.2.2.1. Patch Test
      • 6.2.2.2. Skin Prick Test
  • 6.3. Therapeutic Treatment Type
    • 6.3.1. Antihistamines
    • 6.3.2. Epinephrine Auto-Injector

7. Food Allergy Diagnostics & Therapeutics Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Polymerase Chain Reaction

8. Food Allergy Diagnostics & Therapeutics Market, by Source

  • 8.1. Introduction
  • 8.2. Eggs
  • 8.3. Fish
  • 8.4. Milk
  • 8.5. Peanuts
  • 8.6. Shellfish
  • 8.7. Soy
  • 8.8. Tree Nuts
  • 8.9. Wheat

9. Food Allergy Diagnostics & Therapeutics Market, by Component

  • 9.1. Introduction
  • 9.2. Consumables
  • 9.3. Instruments
  • 9.4. Services

10. Food Allergy Diagnostics & Therapeutics Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Research Institutes
  • 10.3. Diagnostics Laboratories
  • 10.4. Hospitals & Clinics

11. Americas Food Allergy Diagnostics & Therapeutics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Food Allergy Diagnostics & Therapeutics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Food Allergy Diagnostics & Therapeutics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Aleph Farms Increases Production Capabilities With VBL Therapeutics Facility Acquisition And ESCO Aster Partnership
    • 14.3.2. Jerath Path Labs expands the reach in India in allergy-testing
    • 14.3.3. Deeside firm secures US patent for food allergy diagnostics
    • 14.3.4. "Thermo Fisher's Wheat And Sesame Allergy Blood Tests Earn FDA Nod
    • 14.3.5. CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics' Investigational Peanut Allergy Treatment - CoreRx(R)
    • 14.3.6. Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development
    • 14.3.7. Allergy Therapeutics Selects AGC Biologics to Manufacture Peanut Allergy Vaccine Candidate
    • 14.3.8. FDA approves IND application for peanut allergy drug candidate
    • 14.3.9. Praetura Ventures leads £2.9m investment in food allergy diagnostic company
    • 14.3.10. Ukko raises $40 million to address food allergies with AI
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 7 Drops Diagnostics, Inc.
  • 2. ACON Laboratories, Inc.
  • 3. AESKU.GROUP GmbH
  • 4. ALK-Abello A/S
  • 5. Allergy Therapeutics PLC
  • 6. Alpha Laboratories
  • 7. Apexhealth by Acecgt Diagnostic Limited
  • 8. Apollo Diagnostics
  • 9. Aster Clinical Lab LLP
  • 10. Astra Biotech GmbH
  • 11. bioMerieux SA
  • 12. Cerascreen GmbH
  • 13. Eurofins Scientific (Ireland) Limited
  • 14. EUROIMMUN Medizinische Labordiagnostika AG
  • 15. HollisterStier Allergy by Jubilant Pharma Holdings Inc.
  • 16. HYCOR Biomedical
  • 17. Indoor Biotechnologies, Inc.
  • 18. Laboratory Corporation of America Holdings.
  • 19. Lincoln Diagnostics, Inc.
  • 20. Medeca Pharma AB
  • 21. Microbac Laboratories, Inc.
  • 22. Minaris Medical America, Inc.
  • 23. Neogen Corporatio
  • 24. Nestle Health Science
  • 25. Omega Diagnostics Group PLC
  • 26. Prota Therapeutics Pty. Ltd.
  • 27. Quest Consumer Inc.
  • 28. R-Biopharm AG
  • 29. Romer Labs Division Holding GmbH
  • 30. ROXALL Medizin GmbH
  • 31. Siemens AG
  • 32. STALLERGENES GREER International AG
  • 33. Tecan Trading AG
  • 34. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PATCH TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SKIN PRICK TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY EPINEPHRINE AUTO-INJECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY EGGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY MILK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PEANUTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SHELLFISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TREE NUTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY WHEAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC TESTS TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND FOOD ALLERGY DIAGNOSTICS & THERAPEUTICS MARKET SIZE, BY IN VIVO/SKIN, 2018-203